Stephen Simes

Mr. Stephen M.
Simes is an Independent Director at CytoDyn, Inc., an Independent Director at BioLife4D Corp.
and a Chairman at Bio-Xl Ltd. He is on the Board of Directors at CytoDyn, Inc. and BioLife4D Corp.
Mr. Simes was previously employed as an Independent Director by Therapix Biosciences Ltd., a Chief Executive Officer & Director by RestorGenex Corp., a Vice Chairman, President & Chief Executive Officer by BioSante Pharmaceuticals, Inc., a President, Chief Executive Officer & Director by Unimed Pharmaceuticals, Inc., a Director & Senior Vice President by Bio Technology General Corp., a Chairman, President & Chief Executive Officer by Gynex Pharmaceuticals, Inc., a Principal by G.D.
Searle & Co., Inc., and a Chief Executive Officer by Diffusion Pharmaceuticals, Inc. He also served on the board at Ceregene, Inc. and Biotechnology General (Israel) Ltd. He received his undergraduate degree from Brooklyn College and an MBA from New York University.